FdaApplication
ANDA 207594
Identifiers
- fda_app_no: ANDA207594
Properties
| Property | Value |
|---|---|
| applicant_name | HQ SPECIALTY PHARMA CORP |
| application_type | ANDA |
| approval_date | 2019-12-12 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IMIPENEM AND CILASTATIN | CILASTATIN SODIUM; IMIPENEM | EQ 500MG BASE/VIAL;500MG/VIAL | POWDER;INTRAVENOUS |
1 product